We are live on
!
Find out more
GT
Glenmede Trust Portfolio holdings
AUM
$20.4B
This Fund
S&P 500
This Quarter
Est. Return
+6.16%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$25B
AUM Growth
+$2.37B
(+11%)
Cap. Flow
+$1.17B
Cap. Flow
% of AUM
4.67%
Top 10 Holdings %
Top 10 Hldgs %
16.34%
Holding
2,152
New
227
Increased
430
Reduced
632
Closed
714
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$783M |
| 2 |
Genuine Parts
GPC
|
+$573M |
| 3 |
Paychex
PAYX
|
+$431M |
| 4 |
Monster Beverage
MNST
|
+$119M |
| 5 |
Northern Trust
NTRS
|
+$101M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$804M |
| 2 |
Accenture
ACN
|
+$118M |
| 3 |
Sysco
SYY
|
+$76.9M |
| 4 |
Apple
AAPL
|
+$76.7M |
| 5 |
NetApp
NTAP
|
+$69.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.58% |
| 2 | Healthcare | 13.03% |
| 3 | Financials | 12.46% |
| 4 | Consumer Discretionary | 10.73% |
| 5 | Industrials | 9.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
626
Casey's General Stores
CASY
$31.6B
| $1.19M | ﹤0.01% |
9,197
-1,759
| -16% | -$202K |
|
627
Jones Lang LaSalle
JLL
$15.5B
| $1.18M | ﹤0.01% |
8,210
-6,134
| -43% | -$964K |
|
628
Darling Ingredients
DAR
$9.62B
| $1.17M | ﹤0.01% |
60,697
+59,632
| +5,599% | +$1.17M |
|
629
Packaging Corp of America
PKG
$22.5B
| $1.17M | ﹤0.01% |
10,649
-211,558
| -95% | -$23.9M |
|
630
Devon Energy
DVN
$49.8B
| $1.17M | ﹤0.01% |
29,225
-2,692
| -8% | -$115K |
|
631
Vanguard Total International Stock ETF
VXUS
$153B
| $1.17M | ﹤0.01% |
+21,575
| New | +$1.17M |
|
632
Sprott Physical Gold
PHYS
$14.7B
| $1.16M | ﹤0.01% |
121,648
+81,400
| +202% | +$795K |
|
633
CF Industries
CF
$18.4B
| $1.16M | ﹤0.01% |
21,285
-2,923
| -12% | -$141K |
|
634
Leggett & Platt
LEG
$1.5B
| $1.16M | ﹤0.01% |
26,418
-39,313
| -60% | -$1.77M |
|
|
WCC
635
WESCO International
WCC
$16.5B
| $1.16M | ﹤0.01% |
18,820
+9,100
| +94% | +$545K |
|
636
AptarGroup
ATR
$8.51B
| $1.16M | ﹤0.01% |
10,722
-399
| -4% | -$41K |
|
637
Lamb Weston
LW
$7.3B
| $1.16M | ﹤0.01% |
17,355
+11,641
| +204% | +$799K |
|
638
Brown-Forman Class B
BF.B
$12.6B
| $1.15M | ﹤0.01% |
22,823
+1,888
| +9% | +$98.1K |
|
639
SAP
SAP
$200B
| $1.15M | ﹤0.01% |
9,372
+1,029
| +12% | +$122K |
|
640
Martin Marietta Materials
MLM
$34.3B
| $1.15M | ﹤0.01% |
6,316
+4,720
| +296% | +$974K |
|
641
Analog Devices
ADI
$181B
| $1.15M | ﹤0.01% |
12,397
-2,460
| -17% | -$236K |
|
642
Neurocrine Biosciences
NBIX
$17.7B
| $1.13M | ﹤0.01% |
9,220
-8
| -0.1% | -$908 |
|
643
Consolidated Edison
ED
$41.1B
| $1.13M | ﹤0.01% |
14,828
-735
| -5% | -$57.9K |
|
644
Tesla
TSLA
$1.22T
| $1.13M | ﹤0.01% |
64,020
-8,955
| -12% | -$187K |
|
645
Eversource Energy
ES
$28.1B
| $1.13M | ﹤0.01% |
18,346
-53,434
| -74% | -$3.27M |
|
646
Fulton Financial
FULT
$4.67B
| $1.11M | ﹤0.01% |
66,693
-8,100
| -11% | -$142K |
|
647
Blackstone
BX
$106B
| $1.1M | ﹤0.01% |
28,870
+575
| +2% | +$20.8K |
|
648
Intuit
INTU
$83.1B
| $1.09M | ﹤0.01% |
4,808
+10
| +0.2% | +$2.15K |
|
649
Graco
GGG
$13B
| $1.06M | ﹤0.01% |
22,976
-1,334
| -5% | -$62.2K |
|
650
Sanofi
SNY
$105B
| $1.05M | ﹤0.01% |
23,605
+4,324
| +22% | +$185K |
|
Similar funds
SLAM
EWA
MIC
P
OSAM
CB
EIM
Glenmede Trust's Q3 2018 Portfolio in Review
As of Q3 2018, Glenmede Trust held 2,152 positions worth $25B, up 11% from $22.6B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Glenmede Trust deployed $1.17B of net new capital in Q3 2018, opening 227 new positions and adding to 430 existing holdings. Its largest new stake was Vanguard Small-Cap ETF: 518,651 shares worth $84.3M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 18% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Johnson & Johnson, an estimated $804M trimmed.
- Glenmede Trust's largest Q3 2018 buy was Vanguard Small-Cap ETF: 518,651 shares worth $84.3M.
- Glenmede Trust added most to Alphabet (Google) Class A in Q3 2018, an estimated $783M increase.
- Glenmede Trust's biggest Q3 2018 reduction was Johnson & Johnson, cutting an estimated $804M.
- Glenmede Trust fully exited BioTelemetry, Inc. in Q3 2018, selling an estimated $43.4M.
- Glenmede Trust's ten largest holdings make up 16% of its $25B portfolio in Q3 2018.
- Glenmede Trust opened 227 new positions and closed 714 in Q3 2018.
- Glenmede Trust's portfolio value rose 11% quarter-over-quarter to $25B.
Based on Glenmede Trust's 13F filing for Q3 2018, filed 15 Nov 2018.